[KSCI] Korea Science Citation Index Service

http://dx.doi.org/10.1038/emm.2016.103

Aldehyde dehydrogenase is used by cancer cells for energy metabolism

Kang, Joon Hee (Cancer Cell and Molecular Biology Branch, National Cancer Center, Research Institute)
Lee, Seon-Hyeong (Cancer Cell and Molecular Biology Branch, National Cancer Center, Research Institute)
Hong, Dongwan (Cancer Immunology Branch, National Cancer Center, Research Institute)
Lee, Jae-Seon (Cancer Cell and Molecular Biology Branch, National Cancer Center, Research Institute)
Ahn, Hee-Sung (Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology)
Ahn, Ju-Hyun (Department of Biochemistry and Molecular Biology, Ajou University School of Medicine, Genomic Instability Research Center)
Seong, Tae Wha (Cancer Cell and Molecular Biology Branch, National Cancer Center, Research Institute)
Lee, Chang-Hun (Cancer Cell and Molecular Biology Branch, National Cancer Center, Research Institute)
Jang, Hyonchol (Cancer Cell and Molecular Biology Branch, National Cancer Center, Research Institute)
Hong, Kyeong Man (Omics Core Laboratory, National Cancer Center, Research Institute)
Lee, Cheolju (Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology)
Lee, Jae-Ho (Department of Biochemistry and Molecular Biology, Ajou University School of Medicine, Genomic Instability Research Center)
Kim, Soo-Youl (Cancer Cell and Molecular Biology Branch, National Cancer Center, Research Institute)

Publication Information

Experimental and Molecular Medicine / v.48, no.11, 2016 , pp. 6.1-6.13 More about this Journal

Abstract

We found that non-small-cell lung cancer (NSCLC) cells express high levels of multiple aldehyde dehydrogenase (ALDH) isoforms via an informatics analysis of metabolic enzymes in NSCLC and immunohistochemical staining of NSCLC clinical tumor samples. Using a multiple reaction-monitoring mass spectrometry analysis, we found that multiple ALDH isozymes were generally abundant in NSCLC cells compared with their levels in normal IMR-90 human lung cells. As a result of the catalytic reaction mediated by ALDH, NADH is produced as a by-product from the conversion of aldehyde to carboxylic acid. We hypothesized that the NADH produced by ALDH may be a reliable energy source for ATP production in NSCLC. This study revealed that NADH production by ALDH contributes significantly to ATP production in NSCLC. Furthermore, gossypol, a pan-ALDH inhibitor, markedly reduced the level of ATP. Gossypol combined with phenformin synergistically reduced the ATP levels, which efficiently induced cell death following cell cycle arrest.

Keywords

Citations & Related Records

Reference

1	Pao W, Chmielecki J. Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer. Nat Rev Cancer 2010; 10: 760-774. DOI
2	Wong DW, Leung EL, So KK, Tam IY, Sihoe AD, Cheng LC et al. The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS. Cancer 2009; 115: 1723-1733. DOI
3	Li X, Wan L, Geng J, Wu CL, Bai X. Aldehyde dehydrogenase 1A1 possesses stem-like properties and predicts lung cancer patient outcome. J Thorac Oncol 2012; 7: 1235-1245. DOI
4	Jiang F, Qiu Q, Khanna A, Todd NW, Deepak J, Xing L et al. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res 2009; 7: 330-338. DOI
5	Sweet S, Singh G. Changes in mitochondrial mass, membrane potential, and cellular adenosine triphosphate content during the cell cycle of human leukemic (HL-60) cells. J Cell Physiol 1999; 180: 91-96. DOI
6	Januchowski R, Wojtowicz K, Zabel M. The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance. Biomed Pharmacother 2013; 67: 669-680. DOI
7	Kastan MB, Schlaffer E, Russo JE, Colvin OM, Civin CI, Hilton J. Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells. Blood 1990; 75: 1947-1950.
8	Cancer Genome Atlas Research N, Weinstein JN, Collisson EA, Mills GB, Shaw KR, Ozenberger BA et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet 2013; 45: 1113-1120. DOI
9	Sweet S, Singh G. Accumulation of human promyelocytic leukemic (HL-60) cells at two energetic cell cycle checkpoints. Cancer Res 1995; 55: 5164-5167.
10	Ma I, Allan AL. The role of human aldehyde dehydrogenase in normal and cancer stem cells. Stem Cell Rev 2011; 7: 292-306. DOI
11	Deng S, Yang X, Lassus H, Liang S, Kaur S, Ye Q et al. Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers. PLoS ONE 2010; 5: e10277. DOI
12	Kohn FR, Landkamer GJ, Manthey CL, Ramsay NK, Sladek NE. Effect of aldehyde dehydrogenase inhibitors on the ex vivo sensitivity of human multipotent and committed hematopoietic progenitor cells and malignant blood cells to oxazaphosphorines. Cancer Res 1987; 47: 3180-3185.
13	Burgos C, Gerez de Burgos NM, Rovai LE, Blanco A. In vitro inhibition by gossypol of oxidoreductases from human tissues. Biochem Pharmacol 1986; 35: 801-804. DOI
14	Koppaka V, Thompson DC, Chen Y, Ellermann M, Nicolaou KC, Juvonen RO et al. Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application. Pharmacol Rev 2012; 64: 520-539. DOI
15	Rekha GK, Sladek NE. Inhibition of human class 3 aldehyde dehydrogenase, and sensitization of tumor cells that express significant amounts of this enzyme to oxazaphosphorines, by the naturally occurring compound gossypol. Adv Exp Med Biol 1997; 414: 133-146.
16	Ready N, Karaseva NA, Orlov SV, Luft AV, Popovych O, Holmlund JT et al. Double-blind, placebo-controlled, randomized phase 2 study of the proapoptotic agent AT-101 plus docetaxel, in second-line non-small cell lung cancer. J Thorac Oncol 2011; 6: 781-785. DOI
17	Moretti L, Li B, Kim KW, Chen H, Lu B. AT-101, a pan-Bcl-2 inhibitor, leads to radiosensitization of non-small cell lung cancer. J Thorac Oncol 2010; 5: 680-687. DOI
18	Ren T, Shan J, Qing Y, Qian C, Li Q, Lu G et al. Sequential treatment with AT-101 enhances cisplatin chemosensitivity in human non-small cell lung cancer cells through inhibition of apurinic/apyrimidinic endonuclease 1-activated IL-6/STAT3 signaling pathway. Drug Des Dev Ther 2014; 8: 2517-2529.
19	Van Poznak C, Seidman AD, Reidenberg MM, Moasser MM, Sklarin N, Van Zee K et al. Oral gossypol in the treatment of patients with refractory metastatic breast cancer: a phase I/II clinical trial. Breast Cancer Res Treat 2001; 66: 239-248. DOI
20	Guo Q, Liu Z, Jiang L, Hu T, Li D, Liu Y et al. Starvation-induced autophagy in cultured non-small cell lung cancer cells. Nan Fang Yi Ke Da Xue Xue Bao 2014; 34: 627-630.
21	Kitada S, Leone M, Sareth S, Zhai D, Reed JC, Pellecchia M. Discovery, characterization, and structure-activity relationships studies of proapoptotic polyphenols targeting B-cell lymphocyte/leukemia-2 proteins. J Med Chem 2003; 46: 4259-4264. DOI

Reference

3	(2016) Journal of receptors and signal transduction PPARgamma-mediated ALDH1A3 suppression exerts anti-proliferative effects in lung cancer by inducing lipid peroxidation / 38 (3) , 191
7	(2016) Neuro-oncology Regulation of bioenergetics through dual inhibition of aldehyde dehydrogenase and mitochondrial complex I suppresses glioblastoma tumorspheres / 20 (7) , 954
1	(2016) Biomolecules & therapeutics Cancer Energy Metabolism: Shutting Power off Cancer Factory / 26 (1) , 39
None	(2016) Frontiers in oncology “Energetic” Cancer Stem Cells (e-CSCs): A New Hyper-Metabolic and Proliferative Tumor Cell Phenotype, Driven by Mitochondrial Energy / 8 (None) , 677
10	(2016) Experimental & molecular medicine : EMM Farnesyl diphosphate synthase is important for the maintenance of glioblastoma stemness / 50 (10) , 137
None	(2016) Scientific reports Targeting Mitochondrial Oxidative Phosphorylation Abrogated Irinotecan Resistance in NSCLC / 8 (None) , 15707
1	(2016) Drug metabolism reviews Aldehyde toxicity and metabolism: the role of aldehyde dehydrogenases in detoxification, drug resistance and carcinogenesis / 51 (1) , 42
2	(2019) Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea Targeting cancer energy metabolism: a potential systemic cure for cancer / 42 (2) , 140
3	(2019) Aging Hallmarks of the cancer cell of origin: Comparisons with “energetic” cancer stem cells (e-CSCs) / 11 (3) , 1065
16	(2016) Nanomedicine Paclitaxel-encapsulated core-shell nanoparticle of cetyl alcohol for active targeted delivery through oral route / 14 (16) , 2121
9	(2019) Cells Highlights in Resistance Mechanism Pathways for Combination Therapy / 8 (9) , 1013
10	(2019) Biomolecules Gossypol Suppresses Growth of Temozolomide-Resistant Glioblastoma Tumor Spheres / 9 (10) , 595
1	(2016) Scientific reports Gastric cancer depends on aldehyde dehydrogenase 3A1 for fatty acid oxidation / 9 (1) , 16313
12	(2016) ACS central science Development of a Retinal-Based Probe for the Profiling of Retinaldehyde Dehydrogenases in Cancer Cells / 5 (12) , 1965
3	(2016) Biomolecules NAD- and NADPH-Contributing Enzymes as Therapeutic Targets in Cancer: An Overview / 10 (3) , 358
2	(2016) Biotechnologia acta THE APPROACH FOR EXPRESS SPECTROMETRIC DETERMINATION OF THE REDUCED FORM OF NICOTINAMIDE ADENINE DINUCLEOTIDE (NADH) CONTENT / 13 (2) , 32
12	(2016) Experimental biology and medicine Potential biomarkers in septic shock besides lactate / 245 (12) , 1066
7	(2020) Cells Role of Mitochondria-Cytoskeleton Interactions in the Regulation of Mitochondrial Structure and Function in Cancer Stem Cells / 9 (7) , 1691
9	(2016) Cancers ATP Production Relies on Fatty Acid Oxidation Rather than Glycolysis in Pancreatic Ductal Adenocarcinoma / 12 (9) , 2477
9	(2016) Cells Targeting Oxidative Phosphorylation Reverses Drug Resistance in Cancer Cells by Blocking Autophagy Recycling / 9 (9) , 2013
10	(2016) Journal of clinical medicine A Review of GC-Based Analysis of Non-Invasive Biomarkers of Colorectal Cancer and Related Pathways / 9 (10) , 3191
11	(2016) Pharmaceutics Oxoglutarate Carrier Inhibition Reduced Melanoma Growth and Invasion by Reducing ATP Production / 12 (11) , 1128
2	(2021) Cancers A Selective Competitive Inhibitor of Aldehyde Dehydrogenase 1A3 Hinders Cancer Cell Growth, Invasiveness and Stemness In Vitro / 13 (2) , 356
1	(2021) Journal of enzyme inhibition and medicinal chemistry The possible role of methylglyoxal metabolism in cancer / 36 (1) , 2010
6	(2016) Parasitology Potential therapeutic targets shared between leishmaniasis and cancer / 148 (6) , 655
9	(2016) Cancers Reply to Krupenko et al. Comment on “Lee et al. The Combination of Loss of ALDH1L1 Function and Phenformin Treatment Decreases Tumor Growth in KRAS-Driven Lung Cancer Cancers 2020, 12, 1382 / 13 (9) , 2238
9	(2016) The EMBO journal A necessary role of DNMT3A in endurance exercise by suppressing ALDH1L1‐mediated oxidative stress / 40 (9) , None
21	(2021) International journal of molecular sciences Transcriptome Analysis of Pterygium and Pinguecula Reveals Evidence of Genomic Instability Associated with Chronic Inflammation / 22 (21) , 12090
1	(2016) Scientific reports A pan-cancer transcriptomic study showing tumor specific alterations in central metabolism / 11 (1) , 13637